Key statistics
On Tuesday, Eledon Pharmaceuticals Inc (2TK:DEU) closed at 2.24, 6.67% above its 52-week low of 2.10, set on Oct 02, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.36 |
---|---|
High | 2.36 |
Low | 2.20 |
Bid | 2.26 |
Offer | 2.46 |
Previous close | 2.24 |
Average volume | 375.56 |
---|---|
Shares outstanding | 59.88m |
Free float | 59.71m |
P/E (TTM) | 68.77 |
Market cap | 167.07m USD |
EPS (TTM) | 0.0406 USD |
Data delayed at least 15 minutes, as of Jul 01 2025.
More ▼
Announcements
- Eledon Pharmaceuticals to Host R&D Day on July 9, 2025 in New York City
- Eledon Pharmaceuticals Reports First Quarter 2025 Operating and Financial Results
- Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Operating and Financial Results
- Eledon Pharmaceuticals to Participate in Leerink Partners Global Healthcare Conference
- Eledon Pharmaceuticals Announces Use of Tegoprubart as Key Component of Immunosuppression Regimen in its Second Transplant of a Genetically Modified Pig Kidney into a Human
- Eledon Pharmaceuticals to Participate in Guggenheim Securities SMID Cap Biotech Conference
- Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2025 Outlook
- Eledon Pharmaceuticals Announces Recent Business Highlights and Third Quarter 2024 Financial Results
- Eledon Pharmaceuticals to Participate in Guggenheim Securities Inaugural Healthcare Innovation Conference
- Eledon Pharmaceuticals Announces Pricing of $85 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
More ▼